Advising LabTech on one of the largest sales in the London office market
Antiverse and Nxera Pharma enter collaboration to design novel GPCR-targeted antibody therapeutics
Appointment of Senior Pro Bono Lawyer
Taylor Wessing advises Sullivan Street Partners on its sale of Tivoli
Taylor Wessing advises Arrow Electronics, Inc. on the acquisition of iQmine GmbH
Blue Earth Therapeutics raises US$76.5 million Series A funding
Welcoming a new partner to our London financial services regulatory offering
Advising Vinted on its €340 million secondary share sale
Shift Bioscience raises US$16 million seed funding
Recognised as a notable firm in ALB Asia M&A Rankings 2024
Advising Nuclera on its US$75 million series C financing
Taylor Wessing in the news
Jo Joyce speaks to Tech Talk
Jo Joyce explains the DSA and changes likely in store for businesses operating in the EU.
Emma Danks quoted in The Times
Emma Danks comments in The Times via Raconteur on global M&A activity this year and future prospects for deal-seeking companies.
Al Watson quoted in the Financial Times
Al Watson comments in the Financial Times on how the UK Government can create more local houses for local people.
Germany
Germany
UK
Netherlands / Belgium
Austria / CEE/SEE
China / Asia